Tomer Adar

Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

Paloma Cejas, Yotam Drier, Koen M.A. Dreijerink et al. · Nature Medicine · 2019 · 179 citations · Full text

Tumor Biology, Pancreatic Cancer, Medicine +6

Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome

Tomer Adar, Linda Rodgers, Kristen M. Shannon et al. · Cancer · 2018 · 98 citations · Full text

Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study

Tomer Adar, David M. Faleck, Saranya Sasidharan et al. · Alimentary Pharmacology & Therapeutics · 2019 · 95 citations

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial

Gadi Lalazar, Meir Mizrahi, Ilit Turgeman et al. · Journal of Clinical Immunology · 2015 · 75 citations

Autoimmune Disease, Insulin Management, Diabetes +9

Adalimumab-induced Autoimmune Hepatitis

Tomer Adar, Meir Mizrahi, Orit Pappo et al. · Journal of Clinical Gastroenterology · 2009 · 74 citations

Immunology, Dermatology, Immunotherapy +17